Washington University School of Medicine Overview

Trial Radar AI Insights

Washington University School of Medicine

Washington University School of Medicine in St. Louis stands as a premier institution driving cutting-edge clinical research, particularly in oncology and neuroscience, offering trial participants access to innovative therapies through its extensive network of affiliated hospitals and global collaborations. Its patient-centred approach emphasises equitable trial inclusion, advancing treatments for complex diseases like Alzheimer's and cancer while fostering breakthroughs that enhance quality of life for diverse populations.

• Institution Profile: Founded 1891 · St. Louis, United States · Private · medicine.wustl.edu
• Therapeutic Strengths: Cancer, neuroscience, cardiovascular disease
• Research standing: Faculty awarded the Potamkin Prize for Research in Pick's, Alzheimer's, and Related Diseases (2019); multiple faculty elected to the National Academy of Medicine
• Partnerships: BJC HealthCare, Barnes-Jewish Hospital, St. Louis Children's Hospital, Siteman Cancer Network, Dominantly Inherited Alzheimer Network Trials Unit (DIAN-TU) Pharma Consortium

Clinical Research Infrastructure

The clinical research ecosystem at Washington University School of Medicine integrates world-class facilities with a robust network of affiliates, enabling seamless trial conduct across phases from early-stage to large-scale interventional studies. This infrastructure supports over 800 locations worldwide, emphasising multidisciplinary collaboration to accelerate discoveries in high-burden diseases.

Key hospitals and medical centres include Barnes-Jewish Hospital as the flagship adult facility for complex trials in oncology and cardiology, and St. Louis Children's Hospital for paediatric research in infectious diseases and rare conditions. Specialty institutes and research facilities feature the Siteman Cancer Center, a comprehensive cancer institute designated by the National Cancer Institute, focusing on immunotherapy and precision medicine, alongside the Hope Center for Neurological Disorders for neuroscience advancements.

Key Specialties and Therapeutic Focus

• Primary focus areas (prioritised by expertise and reputation):
  • Cancer and oncology, targeting conditions like breast cancer, prostate cancer, multiple myeloma, and colon cancer screening, with high-enrolment trials addressing immunotherapy and genomic profiling
  • Neuroscience, including Alzheimer's disease, dementia, and autosomal dominant Alzheimer's, alongside cardiovascular disease and obesity-related complications
  • Infectious diseases and diabetes, encompassing global health challenges like those in Malawi and Sierra Leone trials
  • Therapeutic modalities employed: Primarily drugs (295 interventions) and behavioural approaches (134), supplemented by biologics (34), devices (82), procedures (79), and radiation (41), with emerging genetic (3) and combination products (3)
  • Leading specialists and their credentials: Randall J. Bateman in Alzheimer's disease; Nancy L. Bartlett and John F. DiPersio in oncology; Timothy J. Ley in oncology and cancer genomics; Jeffrey Millman in diabetes and regenerative medicine
  • Notable treatment breakthroughs and clinical outcomes: Developed a highly precise blood test to detect the earliest stages of Alzheimer's disease (2019), improving early intervention rates and patient prognosis in neurodegenerative trials

Washington University School of Medicine Clinical Trials Landscape

Trial StatisticsApply Below Filters

Washington University School of Medicine leads a vibrant portfolio of 350 active clinical trials as of September 2025, encompassing recruiting, not-yet-recruiting, and active-not-recruiting statuses, with 215 trials actively recruiting participants. These lead-sponsored efforts have enrolled a total of 444,672 individuals across 827 locations, predominantly in the United States (628 sites), reflecting a strong emphasis on large-scale studies in oncology and neuroscience that span adult (321 trials) and older adult (283 trials) populations, alongside 70 paediatric-focused trials. Key institutions like Barnes-Jewish Hospital anchor many U.S.-based sites, while international expansions to Canada and African nations broaden access for diverse enrolments, averaging 1,270 participants per trial and incorporating 743 arm groups for robust comparative outcomes.

Key Clinical Trial Updates

Recent updates include 47 trials modified in the past month, signalling ongoing adaptations in protocols for conditions like obesity and breast cancer to incorporate real-time data. Interim analyses from phase II oncology trials, such as those involving nivolumab, suggest promising efficacy in immunotherapy combinations, with primary completion dates anticipated in late 2025 for several Alzheimer's studies under the DIAN-TU consortium. Upcoming milestones feature regulatory submissions for novel diagnostic tools in cardiovascular disease by mid-2026, alongside breakthrough approvals in cancer genomics that have expedited patient access to targeted therapies.

Trial Innovation

The institution pioneers patient-centric trial designs, including adaptive protocols in neuroscience studies that adjust based on biomarker responses, enhancing efficiency in Alzheimer's research. Integration of digital health tools enables remote monitoring in behavioural interventions for obesity and physical activity, reducing participant burden while leveraging real-world evidence from wearable devices. Observational trials (60 total) further utilise big data analytics to inform interventional strategies, positioning the school as a leader in hybrid models that blend traditional and decentralised approaches.

Clinical Trial Participation Guide

Leverage Trial Radar's participation assistant to simplify your journey: use Simplify for a quick overview of trials, What to Expect to preview involvement steps, and Check Eligibility to assess fit based on your profile. Navigate the Contacts & Locations tab to access site-specific details and connect directly with study coordinators for personalised guidance.

Explore Washington University School of Medicine clinical trials

Ready to learn more? View 50 of 462 studies.